Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|3|255-267

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.3, 2010-01, pp. : 255-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Manipulation of the Immune System: Enhancement of Innate and Adaptive Mucosal Immunity

By  

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 1965-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Innate Immunity in the Mucosal Immune System

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4203-4213

Bentham Science Publishers

Access to resources Recommend Favorite

Defensin Participation in Innate and Adaptive Immunity

By  

Current Pharmaceutical Design, Vol. 13, Iss. 30, 2007-10 ,pp. : 3131-3139

Bentham Science Publishers

Access to resources Recommend Favorite

Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 16, Iss. 2, 2016-06 ,pp. : 79-94

Bentham Science Publishers

Access to resources Recommend Favorite

IRAKs: Key Regulatory Kinases of Innate Immunity

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite